Literature DB >> 3492308

Application of enzyme immunoassays for the confirmation of clinically suspect plague in Namibia, 1982.

J E Williams, L Arntzen, G L Tyndal, M Isaäcson.   

Abstract

An outbreak of plague occurred in Ovamboland, northern Namibia, late in 1982. Blood cultures, sera and blood clots were tested to obtain laboratory confirmations for clinically suspect cases of the disease. Isolation of the bacillus (Yersinia pestis) was attempted from blood cultures; sera were tested for antibody by passive haemagglutination (PHA) and enzyme-linked immunosorbent assay (ELISA). Sera and clots also were tested by ELISA for the specific F1 plague antigen. All the ELISA procedures were based on a monoclonal antibody to F1 antigen to ensure specificity.Thirty-eight cases were confirmed as plague: 50% by isolation, 34% by antibody responses, and 16% by the detection of antigenaemia. All isolates of Y. pestis were capable of producing F1 antigen, and significant antibody responses were observed in bacteriologically confirmed cases with paired sera. Patients who experienced sero-conversion had a higher IgM titre than IgG titre during the first nine days of hospitalization, while patients hospitalized for 17 or more days had IgG titres that were higher than the IgM titres. The relationship between IgM and IgG antibody titres is discussed with reference to identifying very recent infections. PHA titres increased and declined with IgM titres but were lower and more transient.ELISA procedures increased laboratory confirmations of plague by 23% above the numbers achieved using blood cultures and PHA tests alone. The ELISA to detect F1 antigen accounted for 86% of this increase by confirming cases where bacteriological isolation was not done. This ELISA did not replace the requirement for bacteriological isolation, since seven bacteraemic patients did not demonstrate antigenaemia.

Entities:  

Mesh:

Year:  1986        PMID: 3492308      PMCID: PMC2490949     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  Plague in the United States, 1983.

Authors:  A M Barnes; J D Poland
Journal:  MMWR CDC Surveill Summ       Date:  1984

2.  Comparison of passive haemagglutination and enzyme-linked immunosorbent assay for serodiagnosis of plague.

Authors:  J E Williams; L Arntzen; D M Robinson; D C Cavanaugh; M Isaäcson
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

3.  Requirement to confirm the specificity of ELISA reactions.

Authors:  J E Williams; D M Robinson
Journal:  Trans R Soc Trop Med Hyg       Date:  1982       Impact factor: 2.184

4.  A comparison of serological techniques for plague surveillance.

Authors:  A J Shepherd; P A Leman; D E Hummitzsch; R Swanepoel
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

  4 in total
  14 in total

1.  Quantifying serum antiplague antibody with a fiber-optic biosensor.

Authors:  G P Anderson; K D King; L K Cao; M Jacoby; F S Ligler; J Ezzell
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

2.  Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar.

Authors:  B Rasoamanana; F Leroy; P Boisier; M Rasolomaharo; P Buchy; E Carniel; S Chanteau
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

3.  Use of ELISA to reveal rodent infections in plague surveillance and control programmes.

Authors:  J E Williams
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

4.  Detection of Yersinia pestis fraction 1 antigen with a fiber optic biosensor.

Authors:  L K Cao; G P Anderson; F S Ligler; J Ezzell
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

5.  Human immune response to a plague vaccine comprising recombinant F1 and V antigens.

Authors:  E D Williamson; H C Flick-Smith; C Lebutt; C A Rowland; S M Jones; E L Waters; R J Gwyther; J Miller; P J Packer; M Irving
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Identification of encapsulated and non-encapsulated Yersinia pestis by immunofluorescence tests using polyclonal and monoclonal antibodies.

Authors:  A P Phillips; B C Morris; D Hall; M Glenister; J E Williams
Journal:  Epidemiol Infect       Date:  1988-08       Impact factor: 2.451

7.  Detection of Neisseria meningitidis and Yersinia pestis with a novel silicon-based sensor.

Authors:  J M Libby; H G Wada
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

8.  A monoclonal antibody for the specific diagnosis of plague.

Authors:  J E Williams; M K Gentry; C A Braden; G L Tyndal; P L Altieri; S Berman; D M Robinson
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

9.  Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague.

Authors:  P C Oyston; E D Williamson; S E Leary; S M Eley; K F Griffin; R W Titball
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

10.  Simultaneous Immunodetection of Anthrax, Plague, and Tularemia from Blood Cultures by Use of Multiplexed Suspension Arrays.

Authors:  Adva Mechaly; Einat Vitner; Haim Levy; Shay Weiss; Elad Bar-David; David Gur; Michal Koren; Hila Cohen; Ofer Cohen; Emanuelle Mamroud; Morly Fisher
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.